4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-076896
Options or other derivatives
- Director acquired 737,050 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Sigal Charles Elliott Director | 2022-07-01 | Grant or award · Option to purchase Ordinary Shares | +737,050 | 737,050 | D | ||
Loading xslF345X03/tm2220260-3_4seq1.xml…